Despite epidemiological evidence linking dietary calcium and vitamin D to prostate cancer risk, the limited availability of basic and pre-clinical research precludes the development of specific recommendations regarding intake of these nutrients for men at risk of prostate cancer or those living with the disease. Men with prostate cancer may self medicate or seek complementary and alternative medicines, including calcium or vitamin D supplements, however the impact of such practises on disease progression or response to therapy is unknown. In the proposed studies, we will use transgenic, knockout and xenograft animal models to test the hypothesis is that the vitamin D receptor represents a nutritionally modulated growth regulatory gene in prostate. 1,25D, the ligand for the VDR which is derived from vitamin D, induces growth arrest, differentiation and apoptosis in normal and transformed prostate cells. Since dietary calcium is the major determinant of circulating 1,25D, a corollary to this hypothesis is that calcium consumption will indirectly affect prostate cancer via modulation of the vitamin D endocrine system.
Three specific aims have been designed to test this hypothesis:
Aim 1. To determine whether alterations in dietary calcium or VDR signaling can prevent prostate tumorigenesis in a transgenic mouse model.
Aim 2. To assess the impact of dietary calcium and a vitamin D analog on progression of early stage human prostate cancer.
Aim 3. To identify cellular targets for calcium and VDR modulation of prostate tumorigenesis.
In Aim 1 and 2, we will comprehensively evaluate the effects of dietary calcium and vitamin D status on prostate tumor initiation, progression and metastasis and response to anti-androgen therapy. The experiments in Aim 3 will identity gene targets and provide mechanistic understanding of the role of redox signaling in modulating the effects of dietary calcium and vitamin D on normal prostate biology, tumor initiation, local and metastatic progression. These studies are highly responsive to RFA #CA-03-003, Molecular Targets for Nutrients in Prostate Cancer Prevention, and have the potential to impact on dietary recommendations for men at risk for prostate cancer or those living with the disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA101114-06
Application #
7779629
Study Section
Special Emphasis Panel (ZCA1-SRRB-U (J1))
Program Officer
Kim, Young S
Project Start
2003-06-01
Project End
2009-12-31
Budget Start
2009-08-11
Budget End
2009-12-31
Support Year
6
Fiscal Year
2007
Total Cost
$21,014
Indirect Cost
Name
State University of New York at Albany
Department
Other Basic Sciences
Type
Schools of Public Health
DUNS #
152652822
City
Albany
State
NY
Country
United States
Zip Code
12222
Wang, Wei-Lin Winnie; Welsh, Joellen; Tenniswood, Martin (2013) 1,25-Dihydroxyvitamin D3 modulates lipid metabolism in prostate cancer cells through miRNA mediated regulation of PPARA. J Steroid Biochem Mol Biol 136:247-51
Welsh, JoEllen (2012) Cellular and molecular effects of vitamin D on carcinogenesis. Arch Biochem Biophys 523:107-14
Wang, Wei-Lin W; Chatterjee, Namita; Chittur, Sridar V et al. (2011) Effects of 1?,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer 10:58
Mordan-McCombs, Sarah; Brown, Theodore; Wang, Wei-Lin Winnie et al. (2010) Tumor progression in the LPB-Tag transgenic model of prostate cancer is altered by vitamin D receptor and serum testosterone status. J Steroid Biochem Mol Biol 121:368-71
Narvaez, Carmen J; Matthews, Donald; Broun, Emily et al. (2009) Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology 150:651-61
Mordan-McCombs, S; Brown, T; Zinser, G et al. (2007) Dietary calcium does not affect prostate tumor progression in LPB-Tag transgenic mice. J Steroid Biochem Mol Biol 103:747-51
Welsh, JoEllen (2007) Vitamin D and prevention of breast cancer. Acta Pharmacol Sin 28:1373-82
Welsh, Joellen (2007) Targets of vitamin D receptor signaling in the mammary gland. J Bone Miner Res 22 Suppl 2:V86-90
Tenniswood, Martin; Lee, Edmund Chun Yu (2004) On the trail of cell death pathways in prostate cancer. Cancer Biol Ther 3:769-71
Lee, E C Y; Tenniswood, M (2004) Programmed cell death and survival pathways in prostate cancer cells. Arch Androl 50:27-32